X-ray-Induced Photodegradation of Hydrogels by the Incorporation of X-ray-Activated Long Persistent Luminescent Nanoparticles
The development of on-demand degradable hydrogels remains an important challenge. Even though photodegradable hydrogels offer spatiotemporal control over degradation, it is difficult to use ultraviolet, visible, or near-infrared light as a tool for noninvasive triggering in vivo due to the poor tissue-penetration capacity. In contrast, X-ray irradiation can penetrate deep tissue and has virtually no penetration limitations for biological soft tissues. In this study, we propose an X-ray-photodegradation cascade system for hydrogel degradation by incorporating X-ray-activated persistent luminescence nanoparticles (X-PLNPs) into photodegradable hydrogels. A photodegradable 9,10-dialkoxyanthracene-based cross-linker was synthesized and used to prepare photodegradable hydrogels, of which the degradation behavior can be triggered by visible green light. Next, Tb<sup>3+</sup>-doped β-NaLuF<sub>4</sub> was introduced as an X-PLNP that can convert X-rays into visible light centered at 544 nm. The afterglow can even be detected for 4 × 10<sup>3</sup> s after switching off the X-ray irradiation. The X-ray-induced green light emission was demonstrated to trigger photodegradation of the hydrogel. This proof-of-concept system for X-ray irradiation-induced on-demand hydrogel degradation was used to demonstrate X-ray-sensitive drug delivery inside a chicken breast as the in vitro tissue model. As this X-ray-induced cascade degradation of hydrogels can penetrate deep tissues, it is a promising platform for future in vivo applications requiring on-demand triggered hydrogel degradation, such as drug delivery or removal of hydrogel patches, hydrogel adhesives, or hydrogel tissue engineering scaffolds. It should, however, be noted that the hydrogel's X-ray and photoresponsiveness should be further improved to enable future in vivo use.
Authors
- Yanmin Yang (ORCID: https://orcid.org/0000-0002-8507-9971)
- Leipeng Li (ORCID: https://orcid.org/0000-0002-2753-9466)
- Yuangong Zhang (ORCID: https://orcid.org/0000-0001-5264-560X)
- Richard Hoogenboom (ORCID: https://orcid.org/0000-0001-7398-2058)
- Hailei Zhang (ORCID: https://orcid.org/0000-0002-2600-112X)
- Bo Zhang (ORCID: https://orcid.org/0009-0008-8170-6609)
- Shanshan Li (ORCID: https://orcid.org/0000-0002-9346-2364)
- Jiaying Zhong
- Kaiming Zhang (ORCID: https://orcid.org/0000-0001-7831-6070)
- Yonggang Wu (ORCID: https://orcid.org/0000-0002-6521-2376)
Institutions
- Ghent University (BE)
- Hebei University (CN)
Publication Details
- Journal
- Journal of the American Chemical Society
- Published
- 2025-05-05
- DOI
- https://doi.org/10.1021/jacs.4c14477
- Citations
- 7
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 4.72
Funders
- National Natural Science Foundation of China
- Fonds Wetenschappelijk Onderzoek
- Department of Education of Hebei Province
- China Scholarship Council
- Hebei University
- Bijzonder Onderzoeksfonds UGent